The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Mar. 23, 2021

Filed:

May. 01, 2017
Applicant:

Ojai Retinal Technology, Llc, Ojai, CA (US);

Inventors:

Jeffrey K. Luttrull, Ojai, CA (US);

Benjamin W. L. Margolis, Oakland, CA (US);

David B. Chang, Tustin, CA (US);

Assignee:
Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 5/04 (2006.01); A61N 1/40 (2006.01); A61N 5/067 (2006.01); A61B 18/00 (2006.01); A61B 18/18 (2006.01); A61N 2/02 (2006.01); A61N 5/06 (2006.01); A61N 5/02 (2006.01); A61B 18/20 (2006.01); A61N 7/00 (2006.01); A61B 18/22 (2006.01); A61F 9/008 (2006.01); A61N 7/02 (2006.01); A61B 17/00 (2006.01);
U.S. Cl.
CPC ...
A61N 5/0625 (2013.01); A61B 18/20 (2013.01); A61F 9/00821 (2013.01); A61N 1/403 (2013.01); A61N 2/02 (2013.01); A61N 5/025 (2013.01); A61N 5/045 (2013.01); A61N 5/0603 (2013.01); A61N 7/02 (2013.01); A61B 18/1815 (2013.01); A61B 18/22 (2013.01); A61B 2017/00154 (2013.01); A61B 2018/005 (2013.01); A61B 2018/00494 (2013.01); A61B 2018/00589 (2013.01); A61B 2018/00726 (2013.01); A61B 2018/00982 (2013.01); A61B 2018/00994 (2013.01); A61B 2018/20359 (2017.05); A61F 9/00817 (2013.01); A61F 2009/00863 (2013.01); A61N 2005/063 (2013.01); A61N 2005/0604 (2013.01); A61N 2005/0607 (2013.01); A61N 2005/067 (2013.01); A61N 2005/0608 (2013.01); A61N 2005/0609 (2013.01); A61N 2005/0659 (2013.01); A61N 2005/0662 (2013.01); A61N 2007/0004 (2013.01); A61N 2007/0043 (2013.01);
Abstract

A process that provides protective therapy for biological tissues or fluids includes applying a pulsed energy source to a target tissue or a target fluid having a chronic progressive disease or a risk of having a chronic progressive disease to therapeutically or prophylactically treat the target tissue or target fluid. The pulsed energy source has energy parameters selected so as to raise the target tissue or bodily target fluid temperature up to a predetermined temperature for a short period of time to achieve a therapeutic or prophylactic effect, while the average temperature rise of the target tissue or target fluid over a longer period of time is maintained at or below a predetermined level so as not to permanently damage the target tissue or target fluid.


Find Patent Forward Citations

Loading…